Blocking histamine receptor H1 on macrophages with anti-allergy drugs restores T-cell anti-tumor immunity.

被引：0
|
作者：
Li, Hongzhong [1 ]
Xiao, Yi [1 ]
Yao, Jun [1 ]
Yuan, Xiangliang [1 ]
Yin, Xuedong [1 ]
Zhang, Yuan [1 ]
Saito, Yohei [1 ]
Yagita, Hideo [2 ]
Gibbons, Don [1 ]
Yu, Dihua [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Juntendo Univ, Sch Med, Tokyo, Japan
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2794
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sirt2 blockade promotes T cell metabolism and restores the anti-tumor immunity.
    Hamaidi, Imene
    Zhang, Lin
    Kim, Nayoung
    Wang, Min Hsuan
    Iclozan, Cristina
    Fang, Bin
    Liu, Min
    Koomen, John M.
    Berglund, Anders E.
    Yoder, Sean J.
    Yao, Jiqiang
    Engelman, Robert W.
    Creelan, Ben C.
    Conejo-Garcia, Jose R.
    Mule, James J.
    Antonia, Scott J.
    Kim, Sungjune
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
    Ping, Yu
    Shen, Chunyi
    Huang, Bo
    Zhang, Yi
    CELLS, 2022, 11 (19)
  • [3] EFFECTIVE ANTI-TUMOR IMMUNITY FOLLOWING DEPLETION OF T-CELL FUNCTION
    FALK, RE
    NOSSAL, N
    FALK, JA
    CLINICAL RESEARCH, 1977, 25 (05): : A695 - A695
  • [4] Integrin agonists reduce infiltration of tumor-associated macrophages to promote T-cell mediated anti-tumor immunity
    Khan, Samia Q.
    Faridi, Mohd. H.
    Khaliqdina, Shehryar J.
    Barbosa, Antonio J.
    Varner, Judith A.
    Gupta, Vineet
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [5] Interplay between tumor metabolism, vasculature, and T-cell infiltration in anti-tumor immunity
    Colombo, Giorgia
    Kang, Jee Hye
    Serganova, Inna
    Zappasodi, Roberta
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [6] Intra-tumor CpG-oligonucleotide injection induces protective anti-tumor T cell immunity.
    Tary-Lehmann, H
    Stern, BV
    Boehm, BO
    Lonsdorf, AS
    FASEB JOURNAL, 2002, 16 (04): : A338 - A338
  • [7] EFFECTIVE ANTI-TUMOR IMMUNITY FOLLOWING ELIMINATION OF SUPPRESSOR T-CELL FUNCTION
    FALK, RE
    NOSSAL, NA
    FALK, JA
    SURGERY, 1978, 84 (04) : 483 - 489
  • [8] IFN-. Modulated DCsion Making on T-cell Anti-tumor Immunity
    Chang, T. H.
    Alfei, F.
    Ho, P. C.
    SWISS MEDICAL WEEKLY, 2023, 153 : 12S - 13S
  • [9] The emerging role of the branched chain aminotransferases, BCATc and BCATm, for anti-tumor T-cell immunity
    Wetzel, Tanner J.
    Erfan, Sheila C.
    Ananieva, Elitsa A.
    IMMUNOMETABOLISM, 2023, 5 (01)
  • [10] Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing anti-tumor T cell immunity.
    Pyo, Kyoung-Ho
    Lee, Wongeun
    Lee, Hee Kyu
    Kim, Dong Kwon
    Jo, Ha Ni
    Synn, Chun-Bong
    Kim, Jae Hwan
    Byeon, Yeongseon
    Kim, Young Seob
    Ahn, Beung-Chul
    Hong, Min Hee
    Lim, Sun Min
    Cho, Byoung Chul
    Kim, Hye Ryun
    CANCER RESEARCH, 2021, 81 (13)
12345